carbenoxolone sodium has been researched along with Urinary Bladder, Overactive in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balachandran, AA; Contreras-Sanz, A; Curtiss, NL; Duckett, J; Gill, HS; Kelley, S; Khasriya, R; Krska, L; Malone-Lee, J; Mansfield, KJ; Peppiatt-Wildman, CM; Strutt, M; Taylor, KM; Wildman, SS; Wu, C | 1 |
1 other study(ies) available for carbenoxolone sodium and Urinary Bladder, Overactive
Article | Year |
---|---|
Altered urothelial ATP signaling in a major subset of human overactive bladder patients with pyuria.
Topics: Adenosine Triphosphate; Carbenoxolone; Female; Humans; Male; Purinergic P2 Receptor Antagonists; Pyuria; Signal Transduction; Suramin; Uridine Triphosphate; Urinary Bladder; Urinary Bladder, Overactive; Urothelium | 2016 |